Butirrisan

Butirrisan
Product Description

Butirrisan® is a unique formulation containing Clostridium butyricum CBM588, the most documented strain of Clostridium available on the market, which is a high producer of butyrate (one of the most important SCFAs with eubiotic action) in the gut. This uniqueness and its validation through research are its main KEY FEATURES.

FUNCTION AND PURPOSE of Butirrisan® is to increase butyrate production and enhance intestinal epithelial barrier integrity in patients suffering from IBS and IBD and serve as a beneficial supplementation in oncologic patients.

CBM588 is a peculiar bacterial strain documented by more than 30 studies, almost half of those are clinical trials. Moreover, Clostridium butyricum CBM588 has been investigated by 3 international reviews, which highlight especially its beneficial activity in case of IBS, IBD and in oncologic patients.


Pharmextracta Alfa Omega

  • IT
  • 2020
    On CPHI since
  • 100 - 249
    Employees
Company types
Distributor/Import Export
Wholesale/Retail

Pharmextracta Alfa Omega

  • IT
  • 2020
    On CPHI since
  • 100 - 249
    Employees
Company types
Distributor/Import Export
Wholesale/Retail

More Products from Pharmextracta Alfa Omega (3)

  • Berberol

    Product Berberol

    Patented food supplement in film-coated tablets containing Berberine and Silymarin.

    Useful for the regular functionality of the cardiovascular system.

    https://www.berberol.it/en/

  • Crispact

    Product Crispact

    Crispact® is a food supplement in stick packs containing the probiotic strain Lactobacillus crispatus M247.

    Each stick pack contains at least 20 billion CFUs(colony forming units) of Lactobacillus crispatusM247, useful for the balance of bacterial flora.

    https://...
  • Quevir

    Product Quevir

    Food supplement in tablets containing Quercetin Phytosome®.